Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004123
Filing Date
2025-06-10
Accepted
2025-06-10 18:49:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3949
  Complete submission text file 0001950047-25-004123.txt   5448
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33093 | Film No.: 251038441
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIGAND PHARMACEUTICALS INCORPORATED 3911 SORRENTO VALLEY BLVD, SUITE 110 SAN DIEGO CA 92121
Business Address
Reardon Andrew (Reporting) CIK: 0001950232 (see all company filings)

Type: 144